HYPOMAGNESAEMIA AFTER INDUCTION TPF CHEMOTHERAPY FOLLOWED BY CONCOMITANT CISPLATIN/CETUXIMAB/RADIOTHERAPY (CCRT) IN LOCALLY ADVANCED HEAD AND NECK CANCER (LAHNC)

被引：0
|
作者：
Kuhar, C. Grasic [1 ]
Strojan, P. [1 ]
Zakotnik, B. [1 ]
机构：
[1] Inst Oncol, Ljubljana, Slovenia
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：320 / 321
页数：2
相关论文
共 50 条
  • [41] A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced head and neck cancer
    Kim, Brian
    Dillman, Robert O.
    Chen, Peter
    Hafer, Russell
    Cox, Craig
    Barth, Neil
    Carroll, Matthew
    VanderMolen, Louis
    Nguyen, Minh
    Huang, JinChu
    Minion, Annamarie
    Plunkett, Marianne
    Mackintosh, Ralph
    [J]. AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (01) : 93 - 97
  • [42] Concomitant Weekly Cisplatin and Altered Fractionation Radiotherapy in Locally Advanced Head and Neck Cancer
    Newlin, Heather E.
    Amdur, Robert J.
    Riggs, Charles E.
    Morris, Christopher G.
    Kirwan, Jessica M.
    Mendenhall, William M.
    [J]. CANCER, 2010, 116 (19) : 4533 - 4540
  • [43] Induction and concomitant chemoradiotherapy (CCRT) using modified TPF (docetaxel, cisplatin and 5-FU) for the patients with stage IVB advanced head and neck cancer
    Shiga, Kiyoto
    Katagiri, Katsunori
    Saitoh, Daisuke
    Oikawa, Shin-ichi
    Tuchida, Kodai
    Kusaka, Takahiro
    Ohashi, Yu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [44] Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer
    Nakano, Kenji
    Seto, Akira
    Sasaki, Toru
    Shimbashi, Wataru
    Fukushima, Hirofumi
    Yonekawa, Hiroyuki
    Mitani, Hiroki
    Takahashi, Shunji
    [J]. ANTICANCER RESEARCH, 2019, 39 (08) : 4337 - 4342
  • [45] Preliminary report of induction chemotherapy with Docetaxel, Cisplatin, 5FU (TPF) in the treatment of locally advanced Head and Neck cancer
    Kehagioglou, P.
    Ioannidou, G.
    Xesfyngi, D.
    Lagogiannis, G.
    Stavrinidis, I.
    Papala, K.
    Papadogiorgakis, N.
    Katsilieris, I.
    [J]. ONKOLOGIE, 2010, 33 : 127 - 127
  • [46] Radiotherapy combined with Cetuximab for locally advanced head and neck cancer
    Acevedo-Henao, C-M
    Valette, G.
    Marianowski, R.
    Pradier, O.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 96 - 96
  • [47] Cisplatin versus cetuximab plus concomitant radiotherapy in locally advanced head and neck cancer: A meta-analysis of published trials
    Barni, Sandro
    Coinu, Andrea
    Borgonovo, Karen
    Cabiddu, Mary
    Cremonesi, Marco
    Petrelli, Fausto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Induction Chemotherapy Using Gemcitabine and Cisplatin Followed by Hypofractionated Radiation Therapy in Locally Advanced Head and Neck Cancer
    Mateen, A.
    Adil, A. R.
    Khan, M. S.
    Maken, R. N.
    Hashmi, Q. U. A.
    Quraishi, A. M.
    Abdullah, F.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E301 - E302
  • [49] Accelerated weekly concomitant boost postoperative radiation therapy (PORT) combinedto concomitant cisplatin chemotherapy (CT) in patients with locally advanced head and neck cancer (LAHNC)
    Pehlivan, B.
    Zouhair, A.
    Luthi, F.
    Bron, L.
    Pasche, P.
    Seelentag, W.
    Mirimanoff, R. O.
    Ozsahin, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 175 - 175
  • [50] Hyperfractionated radiotherapy versus hyperfractionated radiotherapy and concomitant chemotherapy in locally advanced head and neck cancer
    Kasibhatla, M.
    Prosnitz, L. R.
    Fisher, S. R.
    Scher, R. L.
    Clough, R.
    Brizel, D. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S11 - S12
12345